UF Professor To Expand Proven Disease-Prediction Dashboard To Monitor Gulf Threats
UF researcher Antar Jutla has deployed his Cholera Risk Dashboard in about 20 countries to monitor cholera bacteria using NASA and NOAA satellite images and artificial intelligence algorithms.
UF Researchers Demonstrate GLP-1RAs’ Potential To Treat Depression
UF researchers have found that GLP-1RAs, a class of glucose-lowering medications, may have antidepressant effects in a study funded by the NIH.
Mutations Disrupt Touch-Based Learning, Study Finds
UF researchers, supported by the National Institutes of Health, have found that the Syngap1 gene plays a crucial role in touch-based perception, while certain mutations can lead to mixed signals.
UF Ranked Among World’s Top Universities in Number of Patents
The National Academy of Inventors ranked the University of Florida No. 20 on the list of Top 100 Worldwide Universities Granted Utility Patents in 2024.
Eat Better, Breathe Easier? Research Points To Link Between Diet, Lung Cancer
UF researchers have found that poor diet may influence lung cancer risk, challenging traditional views on diet-related diseases.
Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
UF Team Develops AI Tool To Make Genetic Research More Comprehensive
UF researchers developed PhyloFrame, a machine-learning tool that leverages artificial intelligence to account for ancestral diversity in genetic data, addressing a critical gap in medical genetic research.
Lifeward and MYOLYN Expand Partnership To Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
Lifeward Ltd. and UF startup MYOLYN, Inc., are expanding their exclusive contract to enhance patient access to the MyoCycle FES Cycling Therapy System for home use.
Artificial Intelligence Can Help Predict the Next Pandemic
UF researchers have published an algorithm capable of predicting which COVID-19 variant in circulation today is most likely to become dominant in the next three months.
LightPath Technologies Expands Orlando Workforce Following $27M Acquisition
UF startup LightPath Technologies is expanding its workforce at its Orlando headquarters following a $27 million acquisition, underscoring its continued growth in next-gen optics and imaging systems.
